Mounjaro contains two hormones - GLP1 and GIP and the GIP is said to help reduce the common side effects (such as nausea) Things to be aware of: Clinical trials have shown an average 8% more weight loss using Mounjaro compared to Ozempic/Wegovy
CVS Health, Improving access and affordability to high-cost weight management drugs (2025)
Capazine 9
Studies such as LEADER, SUSTAIN-6, REWIND, SELECT, and most recently the SOUL trial demonstrated that certain GLP-1 receptor agonists were associated with reductions in major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death.[4][5][6][7] Much of the semaglutide cardiovascular evidence, in particular, has shaped how doctors now think about these medicines
Despite this knowledge, data show that the increasing prevalence of unhealthy lifestyles and the associated chronic diseases, especially in Western societies, still need to be controlled